Metraipolis › archive › dc_dbf36905244b
Good response with nivolumab and cabozantinib combination therapy in patients with metastatic collecting duct carcinoma with high expression of PD-L1, c-MET,… — Europe PMC PMID:40921965
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40921965
- DOI
- 10.1007/s13730-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T02:16:29.047Z
- SHA-256 of the archived text
f0384770e366ae041a1b382ad527028eb7c1b63f768676e6d7cf52859376df94- Stable URL of this page
https://metraipolis.com/documento/dc_dbf36905244b
How to cite
Good response with nivolumab and cabozantinib combination therapy in patients with metastatic collecting duct carcinoma with high expression of PD-L1, c-MET,… — Europe PMC PMID:40921965 — Europe PMC (en), https://europepmc.org/article/MED/40921965 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dbf36905244b (Metraipolis archive dc_dbf36905244b, sha256 f0384770e366ae041a1b382ad527028eb7c1b63f768676e6d7cf52859376df94)
BibTeX
@misc{dcdbf36905244b,
title = {Good response with nivolumab and cabozantinib combination therapy in patients with metastatic collecting duct carcinoma with high expression of PD-L1, c-MET,… — Europe PMC PMID:40921965},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40921965},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dbf36905244b; sha256 f0384770e366ae041a1b382ad527028eb7c1b63f768676e6d7cf52859376df94},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40921965. Agents can read the archived copy with the MCP tool read_document.